0001824293-22-000061.txt : 20220706 0001824293-22-000061.hdr.sgml : 20220706 20220706140357 ACCESSION NUMBER: 0001824293-22-000061 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220701 FILED AS OF DATE: 20220706 DATE AS OF CHANGE: 20220706 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Thorell Marella CENTRAL INDEX KEY: 0001826323 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40034 FILM NUMBER: 221068243 MAIL ADDRESS: STREET 1: 1226 CHARTER LANE CITY: AMBLER STATE: PA ZIP: 19002 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Vallon Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001824293 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 824369909 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: TWO LOGAN SQUARE STREET 2: 100 N. 18TH STREET, SUITE 300 CITY: PHILADELPHIA STATE: PA ZIP: 19103 BUSINESS PHONE: (267) 207-3606 MAIL ADDRESS: STREET 1: TWO LOGAN SQUARE STREET 2: 100 N. 18TH STREET, SUITE 300 CITY: PHILADELPHIA STATE: PA ZIP: 19103 4 1 wf-form4_165713062186980.xml FORM 4 X0306 4 2022-07-01 0 0001824293 Vallon Pharmaceuticals, Inc. VLON 0001826323 Thorell Marella C/O VALLON PHARMACEUTICALS, INC. 100 N 18TH STREET, SUITE 300 PHILADELPHIA PA 19103 1 0 0 0 Common Stock 2022-07-01 4 A 0 38023 0 A 38023 D Represents the grant of restricted stock units (RSUs). The RSUs vest in four (4) equal quarterly installments such that the RSU will be fully vested on the first (1st) anniversary of the date of grant, subject to continued service with the Issuer. Each RSU represents the right to receive one share of common stock of Vallon Pharmaceuticals, Inc. /s/ David Baker, attorney-in-fact 2022-07-06